US Stock MarketDetailed Quotes

XRTX XORTX Therapeutics

Watchlist

2.5750
+0.0564+2.24%

Close May 31 16:00 ET

7.48MMarket Cap-1865P/E (TTM)

XORTX Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

47.54%-1.3M

26.56%-6.58M

64.08%-1.3M

-10.66%-1.07M

7.95%-1.73M

0.74%-2.49M

-86.70%-8.96M

-14.81%-3.61M

-6,422.15%-967.56K

-163.88%-1.88M

Net income from continuing operations

-64.79%-3.02M

72.04%-2.16M

204.65%2.7M

-11.38%-1.33M

-36.57%-1.69M

32.24%-1.83M

-388.76%-7.72M

-137.68%-2.58M

81.57%-1.2M

-497.82%-1.24M

Operating gains losses

12,163.50%1.73M

-11.96%-3.66M

-312.04%-3.64M

100.27%2.16K

99.67%-4.58K

92.42%-14.36K

-25.17%-3.26M

90.55%-882.99K

-112.76%-792.44K

-170.53%-1.4M

Depreciation and amortization

-51.93%32.13K

140.25%139.69K

7.99%24.36K

-25.34%16.47K

228.21%32.02K

1,670.31%66.85K

307.58%58.15K

469.33%22.56K

557.56%22.06K

171.95%9.76K

Other non cash items

--224.49K

----

Change In working capital

56.14%-326.87K

-169.94%-1.03M

-70.44%-412.21K

-77.35%222.17K

-122.89%-95.51K

-334.66%-745.19K

236.03%1.47M

68.58%-241.84K

334.93%980.72K

715.62%417.32K

-Change in receivables

-34.20%29.83K

151.20%21.04K

140.47%7.53K

-129.02%-37.83K

108.73%6.01K

153.96%45.33K

-39.87%-41.1K

36.67%-18.61K

--130.36K

-196.92%-68.84K

-Change in prepaid assets

-442.78%-402.07K

-77.09%142.65K

52.92%-148.04K

-53.00%94.74K

-83.12%78.66K

-56.49%117.3K

178.34%622.6K

56.87%-314.46K

1,531.91%201.6K

1,002.75%465.87K

-Change in payables and accrued expense

105.00%45.37K

-233.87%-1.19M

-397.83%-271.7K

-74.53%165.25K

-988.26%-180.18K

-787.81%-907.82K

444.07%892.27K

908.34%91.23K

170.81%648.77K

123.26%20.28K

Cash from discontinued investing activities

Operating cash flow

47.54%-1.3M

26.56%-6.58M

64.08%-1.3M

-10.66%-1.07M

7.95%-1.73M

0.74%-2.49M

-86.70%-8.96M

-14.81%-3.61M

-6,422.15%-967.56K

-163.88%-1.88M

Investing cash flow

Cash flow from continuing investing activities

86.71%-2.62K

-1.45%-46.36K

41.75%-9.8K

-56.50%-7.3K

55.81%-9.54K

-647.39%-19.73K

-43.68%-45.7K

-20.58%-16.82K

50.51%-4.66K

-160.36%-21.58K

Net PPE purchase and sale

--0

78.11%-4.31K

99.98%-1

--0

88.89%-1.64K

---2.67K

---19.7K

---5.42K

--458

---14.73K

Net intangibles purchase and sale

84.62%-2.62K

-61.71%-42.05K

14.02%-9.79K

-42.50%-7.3K

-15.31%-7.9K

-546.14%-17.06K

18.24%-26.01K

18.32%-11.39K

45.65%-5.12K

17.34%-6.85K

Cash from discontinued investing activities

Investing cash flow

86.71%-2.62K

-1.45%-46.36K

41.75%-9.8K

-56.50%-7.3K

55.81%-9.54K

-647.39%-19.73K

-43.68%-45.7K

-20.58%-16.82K

50.51%-4.66K

-160.36%-21.58K

Financing cash flow

Cash flow from continuing financing activities

7,851.59%1.7M

-107.67%-361.04K

-106.03%-312.25K

96.38%-16.67K

-63.72%-10.14K

-21.98K

-75.69%4.71M

-62.80%5.18M

-123.59%-460.78K

-107.55%-6.19K

Net issuance payments of debt

0.73%-15.95K

-223.81%-66.09K

-755.66%-17K

-36.34%-16.67K

-163.98%-16.35K

---16.06K

---20.41K

---1.99K

---12.23K

---6.19K

Net common stock issuance

--2M

--0

----

--0

-72.34%5M

----

Proceeds from stock option exercised by employees

5,497.97%16.57K

362.50%296

--0

--296

-100.00%64

-99.99%64

--0

Net other financing activities

-4,692.38%-297.61K

-9.53%-295.25K

----

---6.21K

61.41%-269.56K

248.81%179K

----

Cash from discontinued financing activities

Financing cash flow

7,851.59%1.7M

-107.67%-361.04K

-106.03%-312.25K

96.38%-16.67K

-63.72%-10.14K

---21.98K

-75.69%4.71M

-62.80%5.18M

-123.59%-460.78K

-107.55%-6.19K

Net cash flow

Beginning cash position

-66.96%3.45M

-29.83%10.43M

-42.86%5.07M

-40.81%6.16M

-36.28%7.91M

-29.83%10.43M

10,954.34%14.87M

126.44%8.87M

150.81%10.41M

159.24%12.41M

Current changes in cash

115.71%397.09K

-62.59%-6.99M

-204.79%-1.62M

23.61%-1.09M

8.26%-1.75M

-0.82%-2.53M

-129.57%-4.3M

-85.63%1.55M

-522.12%-1.43M

-198.75%-1.91M

Effect of exchange rate changes

-903.19%-9.32K

102.97%4.04K

-109.02%-1.45K

99.78%-246

105.02%4.58K

-97.60%1.16K

-169.51%-136.15K

-91.78%16.1K

---109.44K

---91.23K

End cash Position

-51.50%3.84M

-66.96%3.45M

-42.86%5.07M

-40.81%6.16M

-36.28%7.91M

-29.83%10.43M

126.44%8.87M

150.81%10.41M

Free cash flow

47.84%-1.31M

26.41%-6.63M

63.98%-1.31M

-10.88%-1.08M

8.49%-1.74M

0.06%-2.5M

-86.42%-9.01M

-14.83%-3.63M

-3,907.55%-972.22K

-163.84%-1.9M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	47.54%-1.3M	26.56%-6.58M	64.08%-1.3M	-10.66%-1.07M	7.95%-1.73M	0.74%-2.49M	-86.70%-8.96M	-14.81%-3.61M	-6,422.15%-967.56K	-163.88%-1.88M
Net income from continuing operations	-64.79%-3.02M	72.04%-2.16M	204.65%2.7M	-11.38%-1.33M	-36.57%-1.69M	32.24%-1.83M	-388.76%-7.72M	-137.68%-2.58M	81.57%-1.2M	-497.82%-1.24M
Operating gains losses	12,163.50%1.73M	-11.96%-3.66M	-312.04%-3.64M	100.27%2.16K	99.67%-4.58K	92.42%-14.36K	-25.17%-3.26M	90.55%-882.99K	-112.76%-792.44K	-170.53%-1.4M
Depreciation and amortization	-51.93%32.13K	140.25%139.69K	7.99%24.36K	-25.34%16.47K	228.21%32.02K	1,670.31%66.85K	307.58%58.15K	469.33%22.56K	557.56%22.06K	171.95%9.76K
Other non cash items	--224.49K	----	----	----	----	----	----	----	----	----
Change In working capital	56.14%-326.87K	-169.94%-1.03M	-70.44%-412.21K	-77.35%222.17K	-122.89%-95.51K	-334.66%-745.19K	236.03%1.47M	68.58%-241.84K	334.93%980.72K	715.62%417.32K
-Change in receivables	-34.20%29.83K	151.20%21.04K	140.47%7.53K	-129.02%-37.83K	108.73%6.01K	153.96%45.33K	-39.87%-41.1K	36.67%-18.61K	--130.36K	-196.92%-68.84K
-Change in prepaid assets	-442.78%-402.07K	-77.09%142.65K	52.92%-148.04K	-53.00%94.74K	-83.12%78.66K	-56.49%117.3K	178.34%622.6K	56.87%-314.46K	1,531.91%201.6K	1,002.75%465.87K
-Change in payables and accrued expense	105.00%45.37K	-233.87%-1.19M	-397.83%-271.7K	-74.53%165.25K	-988.26%-180.18K	-787.81%-907.82K	444.07%892.27K	908.34%91.23K	170.81%648.77K	123.26%20.28K
Cash from discontinued investing activities
Operating cash flow	47.54%-1.3M	26.56%-6.58M	64.08%-1.3M	-10.66%-1.07M	7.95%-1.73M	0.74%-2.49M	-86.70%-8.96M	-14.81%-3.61M	-6,422.15%-967.56K	-163.88%-1.88M
Investing cash flow
Cash flow from continuing investing activities	86.71%-2.62K	-1.45%-46.36K	41.75%-9.8K	-56.50%-7.3K	55.81%-9.54K	-647.39%-19.73K	-43.68%-45.7K	-20.58%-16.82K	50.51%-4.66K	-160.36%-21.58K
Net PPE purchase and sale	--0	78.11%-4.31K	99.98%-1	--0	88.89%-1.64K	---2.67K	---19.7K	---5.42K	--458	---14.73K
Net intangibles purchase and sale	84.62%-2.62K	-61.71%-42.05K	14.02%-9.79K	-42.50%-7.3K	-15.31%-7.9K	-546.14%-17.06K	18.24%-26.01K	18.32%-11.39K	45.65%-5.12K	17.34%-6.85K
Cash from discontinued investing activities
Investing cash flow	86.71%-2.62K	-1.45%-46.36K	41.75%-9.8K	-56.50%-7.3K	55.81%-9.54K	-647.39%-19.73K	-43.68%-45.7K	-20.58%-16.82K	50.51%-4.66K	-160.36%-21.58K
Financing cash flow
Cash flow from continuing financing activities	7,851.59%1.7M	-107.67%-361.04K	-106.03%-312.25K	96.38%-16.67K	-63.72%-10.14K	-21.98K	-75.69%4.71M	-62.80%5.18M	-123.59%-460.78K	-107.55%-6.19K
Net issuance payments of debt	0.73%-15.95K	-223.81%-66.09K	-755.66%-17K	-36.34%-16.67K	-163.98%-16.35K	---16.06K	---20.41K	---1.99K	---12.23K	---6.19K
Net common stock issuance	--2M	--0	----	----	----	--0	-72.34%5M	----	----	----
Proceeds from stock option exercised by employees	5,497.97%16.57K	362.50%296	--0	--0	--0	--296	-100.00%64	-99.99%64	--0	--0
Net other financing activities	-4,692.38%-297.61K	-9.53%-295.25K	----	----	----	---6.21K	61.41%-269.56K	248.81%179K	----	----
Cash from discontinued financing activities
Financing cash flow	7,851.59%1.7M	-107.67%-361.04K	-106.03%-312.25K	96.38%-16.67K	-63.72%-10.14K	---21.98K	-75.69%4.71M	-62.80%5.18M	-123.59%-460.78K	-107.55%-6.19K
Net cash flow
Beginning cash position	-66.96%3.45M	-29.83%10.43M	-42.86%5.07M	-40.81%6.16M	-36.28%7.91M	-29.83%10.43M	10,954.34%14.87M	126.44%8.87M	150.81%10.41M	159.24%12.41M
Current changes in cash	115.71%397.09K	-62.59%-6.99M	-204.79%-1.62M	23.61%-1.09M	8.26%-1.75M	-0.82%-2.53M	-129.57%-4.3M	-85.63%1.55M	-522.12%-1.43M	-198.75%-1.91M
Effect of exchange rate changes	-903.19%-9.32K	102.97%4.04K	-109.02%-1.45K	99.78%-246	105.02%4.58K	-97.60%1.16K	-169.51%-136.15K	-91.78%16.1K	---109.44K	---91.23K
End cash Position	-51.50%3.84M	-66.96%3.45M	-66.96%3.45M	-42.86%5.07M	-40.81%6.16M	-36.28%7.91M	-29.83%10.43M	-29.83%10.43M	126.44%8.87M	150.81%10.41M
Free cash flow	47.84%-1.31M	26.41%-6.63M	63.98%-1.31M	-10.88%-1.08M	8.49%-1.74M	0.06%-2.5M	-86.42%-9.01M	-14.83%-3.63M	-3,907.55%-972.22K	-163.84%-1.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall